Skip to main content
. 2018 Jul 30;7(10):e1494677. doi: 10.1080/2162402X.2018.1494677

Figure 2.

Figure 2.

Survival analyses and pathway enrichments for lung cancer patients in ever- and never-smokers. (A) Overall survival of lung adenocarcinoma patients in ever- and never-smokers. (B) Recurrence-free survival of lung adenocarcinoma patients in ever- and never-smokers. (C) Pathways enriched by genes significantly downregulated (left) and upregulated (right) in tumor samples from smokers as compared with those from never-smokers. (D) Pathways enriched by DEGs in the tumor-normal comparison in never-smokers (left) and in ever-smokers (right).